2002
DOI: 10.1016/s0166-0934(01)00452-9
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of an enzyme-linked immunosorbent assay for detection of antibodies to Junin virus in rodents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0
3

Year Published

2005
2005
2024
2024

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(9 citation statements)
references
References 11 publications
0
6
0
3
Order By: Relevance
“…The application of reverse transcriptase PCR (RT-PCR) and TaqMan PCR for detection of the JUNV, MACV, and GTOV genomes has been reported (1,11,12,27). Serological diagnosis is also useful for the diagnosis of AHF, especially in patients in the convalescent phase (7,17,19,20,26).…”
Section: Discussionmentioning
confidence: 99%
“…The application of reverse transcriptase PCR (RT-PCR) and TaqMan PCR for detection of the JUNV, MACV, and GTOV genomes has been reported (1,11,12,27). Serological diagnosis is also useful for the diagnosis of AHF, especially in patients in the convalescent phase (7,17,19,20,26).…”
Section: Discussionmentioning
confidence: 99%
“…For the diagnosis of Lassa fever, ELISA assays have recently proved as reliable as indirect fluorescent antibody testing, the previous standard method of viral identification [57]. Junin virus, the cause of Argentine hemorrhagic fever, has been identified using ELISA assays to detect Junin IgG antibodies in infected rodents [58]. More recently, PCR assays have become available for both Lassa and Junin, and a PCR has been developed that predictably amplifies any member of the Arenaviridae family by targeting a highly conserved RNA terminal segment [59].…”
Section: Diagnostic Studiesmentioning
confidence: 99%
“…AHF is a disease of mandatory reporting in Argentina. ELISA is the routine assay for the etiologic confirmation of clinical diagnosis for convalescent patients and for the surveillance of the zoonosis [Riera et al, 1997;Morales et al, 2002]. Nevertheless, the use of the live virus for the production of antigens represents a potential risk and restricts its production to facilities with biosafety levels between 2 and 3 in Argentina, which depends on the strain employed (attenuated or not).…”
Section: Introductionmentioning
confidence: 99%